Natalie Ozburn

<i>KRAS</i>Mutation Is an Important Predictor of Resistance to Therapy with Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer

Erminia Massarelli, Marileila Varella‐Garcia, Ximing Tang et al. · Clinical Cancer Research · 2007 · 600 citations · Full text

Medicine, Molecular Genetics, Oncology +17

Nrf2 and Keap1 Abnormalities in Non–Small Cell Lung Carcinoma and Association with Clinicopathologic Features

Luisa M. Solis, Carmen Behrens, Wenli Dong et al. · Clinical Cancer Research · 2010 · 424 citations · Full text

Medicine, Molecular Biology, Oncology +17

Integrated Array-Comparative Genomic Hybridization and Expression Array Profiles Identify Clinically Relevant Molecular Subtypes of Glioblastoma

Janice Nigro, Anjan Misra, Li Zhang et al. · Cancer Research · 2005 · 324 citations · Full text

Medicine, Genetics, Oncology +15

Nuclear factor‐κB (nf‐κB) is frequently expressed in lung cancer and preneoplastic lesions

Ximing Tang, Diane Liu, Shishir Shishodia et al. · Cancer · 2006 · 189 citations · Full text

Medicine, Molecular Biology, Oncology +16

Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with <i>EGFR</i> Mutation

Maria Gabriela Raso, Carmen Behrens, Matthew H. Herynk et al. · Clinical Cancer Research · 2009 · 156 citations · Full text

Medicine, Oncology, Pathology +16